Showing results (31-40 of 104) with videos related to
Sort By:
Pageof 11
Diabetes, Obesity & Metabolism|August 4, 2018
Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetesAnna Neyman, Jennifer Nelson, Sarah A Tersey, et al.Plos One|May 26, 2018
Immune reconstitution in ART treated, but not untreated HIV infection, is associated with abnormal beta cell functionEmily K Sims, Grace Park, Kieren J Mather, et al.Diabetologia|March 11, 2017
MicroRNA 21 targets BCL2 mRNA to increase apoptosis in rat and human beta cellsEmily K Sims, Alexander J Lakhter, Emily Anderson-Baucum, et al.Diabetes Care|November 6, 2025
Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on TeplizumabChantal Mathieu, Emily K Sims, Lucienne Chatenoud, et al.Communications Medicine|October 4, 2023
Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic reviewJamie L Felton, Kurt J Griffin, Richard A Oram, et al.Clinical Epigenetics|August 2, 2020
Circulating unmethylated CHTOP and INS DNA fragments provide evidence of possible islet cell death in youth with obesity and diabetesFarooq Syed, Sarah A Tersey, Jean-Valery Turatsinze, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 27, 2025
Altered B cell metabolic pathways characterize type 1 diabetes progressionHolly Conway, Jessica Bernard, Rachel Ramos, et al.Clinical Endocrinology|March 27, 2012
Inhibin B and luteinizing hormone levels in girls aged 6-11 years from NHANES III, 1988-1994Emily K Sims, O Y Addo, Audra L Gollenberg, et al.Seminars in Immunology|August 29, 2025
Autoimmune diabetes and targets for immunomodulationCamillo Bechi Genzano, Tyla Young, Rachel Bonami, et al.Laboratory Animals|June 14, 2013
Streptozotocin is equally diabetogenic whether administered to fed or fasted miceZunaira Z Chaudhry, David L Morris, Dan R Moss, et al.Pageof 11